Volume 149, Issue 2, Pages (August 2015)

Slides:



Advertisements
Similar presentations
Philippe Mathurin, Antoine Hollebecque, Laurent Arnalsteen§,, David Buob¶, Emmanuelle Leteurtre¶, Robert Caiazzo§,, Marie Pigeyre#, Hélène Verkindt, Sébastien.
Advertisements

Volume 146, Issue 5, Pages e6 (May 2014)
Volume 148, Issue 4, Pages (April 2015)
Volume 153, Issue 3, Pages e7 (September 2017)
Volume 135, Issue 3, Pages (September 2008)
Volume 153, Issue 3, Pages e7 (September 2017)
Evaluation and Management of End-Stage Liver Disease in Children
Volume 144, Issue 5, Pages (May 2013)
Volume 133, Issue 1, Pages (July 2007)
Outcomes Among Living Liver Donors
Volume 135, Issue 4, Pages (October 2008)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients 
Volume 149, Issue 2, Pages (August 2015)
Amnon Sonnenberg, Richard H. Lash, Robert M. Genta  Gastroenterology 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 128, Issue 7, Pages (June 2005)
Clinical Challenges and Images in GI
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages (March 2018)
Volume 137, Issue 2, Pages (August 2009)
Volume 149, Issue 3, Pages e8 (September 2015)
Abstracts from Around the World
Volume 140, Issue 7, Pages e3 (June 2011)
Volume 152, Issue 5, Pages e1 (April 2017)
Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients  Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens,
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients  Dima L. Diab, Lisa Yerian, Philip.
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis  Jean–François Dufour, Carl M. Oneta, Jean–Jacques.
Bariatric surgery for curing NASH in the morbidly obese?
Volume 146, Issue 5, Pages e6 (May 2014)
Volume 143, Issue 2, Pages (August 2012)
Volume 155, Issue 6, Pages (December 2018)
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva 
Volume 137, Issue 2, Pages (August 2009)
Postprandial Uridine Physiology Is Altered by Obesity
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Rajasekhara R. Mummadi, Krishna S
Efficacy and Safety of a Magnesium Sulfate–Rich Natural Mineral Water for Patients With Functional Constipation  Christophe Dupont, Alain Campagne, Florence.
Volume 149, Issue 2, Pages e5 (August 2015)
Histologic Predictors of Fibrosis Progression in Liver Allografts in Patients With Hepatitis C Virus Infection  Zina Meriden, Kimberly A. Forde, Theresa.
Volume 150, Issue 3, Pages (March 2016)
Volume 149, Issue 2, Pages e8 (August 2015)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection  Elliot.
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 135, Issue 1, Pages (July 2008)
Volume 152, Issue 1, Pages (January 2017)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis  Yung Lee, Aristithes G. Doumouras,
Volume 135, Issue 6, Pages e2 (December 2008)
The Dawning of a New Editorial Board for Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Baby-Epsilon Steps Toward the Triple Aim
Volume 148, Issue 5, Pages e4 (May 2015)
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 142, Issue 6, Pages e4 (May 2012)
Volume 145, Issue 6, Pages e2 (December 2013)
David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Reply Gastroenterology
Volume 138, Issue 6, Pages (May 2010)
Volume 152, Issue 5, Pages e1 (April 2017)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Controversies in Liver Transplantation for Hepatitis C
Early prediction of failure to lose weight after obesity surgery
Covering the Cover Gastroenterology
Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus
Volume 156, Issue 4, Pages (March 2019)
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Volume 149, Issue 2, Pages 379-388 (August 2015) Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients  Guillaume Lassailly, Robert Caiazzo, David Buob, Marie Pigeyre, Hélène Verkindt, Julien Labreuche, Violeta Raverdy, Emmanuelle Leteurtre, Sébastien Dharancy, Alexandre Louvet, Monique Romon, Alain Duhamel, François Pattou, Philippe Mathurin  Gastroenterology  Volume 149, Issue 2, Pages 379-388 (August 2015) DOI: 10.1053/j.gastro.2015.04.014 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Flow chart. Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 (A) Distribution of NASH inflammatory activity grade (severity) before and 1 year after surgery, according to the Brunt score. Data are reported for 82 patients with paired liver biopsies before and 1 year after surgery. (Before surgery: Brunt 1: n = 52; Brunt 2: n = 21; Brunt 3: n = 9. After surgery: Brunt 0: n = 70; Brunt 1: n = 8; Brunt 2: n = 3; Brunt 3: n = 1). P value for comparison of Brunt score before and after surgery <.0001 (Wilcoxon signed rank test). (B) Distribution of NAS before and 1 year after surgery. Data are reported for 82 patients with paired liver biopsies before and 1 year after surgery. (Before surgery, NAS 3: n = 6; NAS 4: n = 25; NAS 5: n = 32; NAS 6: n = 12; NAS 7: n = 7. After surgery, NAS 0: n = 15; NAS 1: n = 37; NAS 2: n = 12; NAS 3: n = 6; NAS 4: n = 6; NAS 5: n = 5; NAS 6: n = 1; NAS 7: n = 0). P value for comparison of NAS score before and after surgery <.0001 (Wilcoxon signed rank test). Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions

Figure 3 Change of histologic features 1 year after bariatric surgery. (A) Percentage of improvement in hepatocellular ballooning and in lobular inflammation 1 year after bariatric surgery. (B) Median of NAS and steatosis at baseline and at 1 year after surgery. ∗Wilcoxon signed rank test. Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions

Figure 4 Distribution of fibrosis stage before and 1 year after surgery: Metavir score. Wilcoxon signed rank paired t test: P < .003. Fibrosis evolution (fibrosis staged with Metavir score) (n = 80∗/82) with paired liver biopsies before and 1 year after surgery. Before surgery F0: n = 22; F1: n = 32; F2: n = 17; F3: n = 6; F4: n = 3. After surgery F0: n = 35; F1: n = 26; F2: n = 11; F3: n = 6; F4: n = 2). ∗For 1 patient, Kleiner score was staged, but Metavir scale staging was missing and another patient could not have fibrosis evaluation due to sample size. Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions

Supplementary Figure Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions

Supplementary Table Gastroenterology 2015 149, 379-388DOI: (10.1053/j.gastro.2015.04.014) Copyright © 2015 AGA Institute Terms and Conditions